FDA Clears Handheld Device for TBI Assessment FDA Clears Handheld Device for TBI Assessment

The Ahead 300 device from BrainScope rapidly and objectively assesses the likelihood of TBI at the point of care.FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news